Lipid vesicles having N,N-dimethylamide derivatives as their primary
lipid
    12.
    发明授权
    Lipid vesicles having N,N-dimethylamide derivatives as their primary lipid 失效
    具有N,N-二甲酰胺衍生物作为主要脂质的脂质体

    公开(公告)号:US5213805A

    公开(公告)日:1993-05-25

    申请号:US735645

    申请日:1991-07-25

    CPC classification number: A61K9/1272 A01N47/48 Y10T428/2984

    Abstract: The present invention concerns lipid vesicles having dimethylamides as their primary structural lipid. Preferred dimethylamides useful in the invention are DMATO and DMASO oils. These vesicles are useful as carriers of water immiscible oily material such as fungicides. In a most preferred aspect, the invention has DMATO vesicles with TCMTB as a fungicide in trapped therein. The vesicles can be made rapidly and provide aqueous dispersion of these materials without the need for additional organic solvents.

    Abstract translation: 本发明涉及具有二甲酰胺作为其主要结构脂质的脂质囊泡。 用于本发明的优选的二甲基酰胺是DMATO和DMASO油。 这些囊泡可用作水不混溶油性物质如杀真菌剂的载体。 在最优选的方面,本发明具有DMATO囊泡,其中TCMTB作为杀真菌剂被捕获。 可以快速制备囊泡,并提供这些材料的水性分散体,而不需要额外的有机溶剂。

    MAHONIA AQUIFOLIM EXTRACT, EXTRACTION PROCESS AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
    13.
    发明申请
    MAHONIA AQUIFOLIM EXTRACT, EXTRACTION PROCESS AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME 失效
    MAHONIA AQUIFOLIM提取物,提取方法和含有其的药物组合物

    公开(公告)号:US20070148226A1

    公开(公告)日:2007-06-28

    申请号:US11682602

    申请日:2007-03-06

    Abstract: The present invention provides a skin treatment composition comprising a Mahonia aquifolium extract in a liposome delivery system. The Mahonia aquifolium extract is present in the skin treatment composition in a range of from 5% to 20% by weight of the total composition. The skin treatment composition is particularly effective in the treatment of psoriasis, eczema and other dry skin conditions. The invention further provides a process for obtaining an extract of Mahonia aquifolium.

    Abstract translation: 本发明提供一种在脂质体递送系统中包含马鞭草提取物的皮肤处理组合物。 马鞭草提取物以总组合物的5重量%至20重量%的范围存在于皮肤处理组合物中。 皮肤治疗组合物在治疗牛皮癣,湿疹和其它干性皮肤病症中特别有效。 本发明还提供了一种获得马鞭草提取物的方法。

    Methods, uses and compositions of fluid petrolatum
    14.
    发明授权
    Methods, uses and compositions of fluid petrolatum 有权
    流体凡士林的方法,用途和组成

    公开(公告)号:US06309664B1

    公开(公告)日:2001-10-30

    申请号:US09396535

    申请日:1999-09-15

    CPC classification number: A61Q17/00 A61K8/14 A61K8/31 Y10S514/847 Y10T428/2984

    Abstract: A fluid preparation of petrolatum capable of being sprayed on to a surface. The preparation includes paucilamellar lipid vesicles containing the petrolatum. Preferably, petrolatum comprises about 20-30% or more of the total weight of the vesicles. Methods of protecting the skin of mammals using the fluid preparation of petrolatum are also discussed.

    Abstract translation: 能够喷洒在表面上的凡士林的流体制剂。 该制剂包括含有凡士林的薄膜脂质囊泡。 优选地,凡士林含有囊泡总重量的约20-30%或更多。 还讨论了使用凡士林流体制剂保护哺乳动物皮肤的方法。

    Extended duration antacid product
    18.
    发明授权
    Extended duration antacid product 失效
    延长使用时间的抗酸产品

    公开(公告)号:US5490985A

    公开(公告)日:1996-02-13

    申请号:US210645

    申请日:1994-03-18

    CPC classification number: A61K9/1272 A61K33/10

    Abstract: An antacid product having extended duration of residence in the gastric and upper intestinal systems has been developed. This antacid product includes a blend of 10-70% by volume nonphospholipid lipid vesicles, with a particulate base. An antiflatulence agent may also be included. A method of providing extended duration amelioration of acid build up in the gastric and upper intestinal tract using this product is also disclosed.

    Abstract translation: 已经开发了在胃和上肠系统中延长持续时间的抗酸产品。 该抗酸产品包括10-70体积%的非脂质脂质囊泡与颗粒基质的混合物。 还可以包括抗溢流剂。 还公开了使用该产品在胃和上肠道中延长持续时间改善酸积累的方法。

Patent Agency Ranking